Drug profile · INN
lincomycin
LINCOMYCIN SXP
lincomycin (LINCOMYCIN SXP) is a bacterial 70s ribosome inhibitor. Associated with Pfizer Australia Pty Ltd.
TGA: approved
Patents linked 0
Pipeline programs 0
News articles 0
Drug details — lincomycin
- Class
- —
- Route
- —
- Patents
- 0
- Programs
- 0
- Data quality
- 0.81
Quick answer
lincomycin (LINCOMYCIN SXP) is a bacterial 70s ribosome inhibitor. Associated with Pfizer Australia Pty Ltd.
Key facts
INN lincomycin
Brand LINCOMYCIN SXP
Mechanism Bacterial 70S ribosome inhibitor
Target Bacterial 70S ribosome
Originator Pfizer Australia Pty Ltd
Mechanism of action
Bacterial 70S ribosome inhibitor
Primary target: Bacterial 70S ribosome
Approval history
| Authority | Status | Date |
|---|---|---|
| TGA | approved | — |
Related & competitor drugs
Frequently asked questions
What is lincomycin?
lincomycin (LINCOMYCIN SXP) is a bacterial 70s ribosome inhibitor. Associated with Pfizer Australia Pty Ltd.
What is the brand name for lincomycin?
LINCOMYCIN SXP is a marketed brand name for lincomycin. Check FDA Drugs@FDA for the current US label holder and prescribing information.